Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inequitable Poverty Exposures: A Subspecialty Opportunity to Address Disparities.
Karvonen KA, Umaretiya PJ, Koch VB, Flamand Y, Aziz-Bose R, Ilcisin L, Valenzuela A, Cole PD, Gennarini LM, Kahn JM, Kelly KM, Tran TH, Michon B, Welch JJG, Wolfe J, Silverman LB, Rosenberg AR, Bona K. Karvonen KA, et al. Among authors: silverman lb. Hosp Pediatr. 2024 Feb 1;14(2):e104-e106. doi: 10.1542/hpeds.2023-007482. Hosp Pediatr. 2024. PMID: 38239110 No abstract available.
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols.
Valtis YK, Flamand Y, Shimony S, Place AE, Silverman LB, Vrooman LM, Brunner AM, Sallan SE, Wadleigh M, Stone RM, DeAngelo DJ, Luskin MR. Valtis YK, et al. Among authors: silverman lb. Leukemia. 2024 Mar;38(3):482-490. doi: 10.1038/s41375-023-02115-4. Epub 2024 Jan 5. Leukemia. 2024. PMID: 38177437
Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium.
Welch JJG, Flamand Y, Stevenson KE, Neuberg DS, Athale UH, Kelly KM, Laverdiere C, Michon B, Place AE, Sallan SE, Silverman LB, Vrooman LM. Welch JJG, et al. Among authors: silverman lb. Pediatr Blood Cancer. 2023 Nov;70(11):e30560. doi: 10.1002/pbc.30560. Epub 2023 Jul 17. Pediatr Blood Cancer. 2023. PMID: 37461125 Clinical Trial.
Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors.
Tsai HK, Gogakos T, Lip V, Tsai JM, Li YD, Fisch AS, Weiss J, Yang W, Grimmett L, DiToro D, Schaefer EJ, Lindsley RC, Tran TH, Caron M, Langlois S, Sinnett D, Pikman Y, Nardi V, Kim AS, Silverman LB, Harris MH. Tsai HK, et al. Among authors: silverman lb. J Mol Diagn. 2023 Sep;25(9):665-681. doi: 10.1016/j.jmoldx.2023.06.007. Epub 2023 Jul 5. J Mol Diagn. 2023. PMID: 37419244
Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial.
Hunger SP, Tran TH, Saha V, Devidas M, Valsecchi MG, Gastier-Foster JM, Cazzaniga G, Reshmi SC, Borowitz MJ, Moorman AV, Heerema NA, Carroll AJ, Martin-Regueira P, Loh ML, Raetz EA, Schultz KR, Slayton WB, Cario G, Schrappe M, Silverman LB, Biondi A. Hunger SP, et al. Among authors: silverman lb. Lancet Haematol. 2023 Jul;10(7):e510-e520. doi: 10.1016/S2352-3026(23)00088-1. Lancet Haematol. 2023. PMID: 37407142 Clinical Trial.
206 results